PHARMACEUTICAL EXPORT COMPOSITION AND ITS ASSOCIATION WITH NATIONAL PHARMACEUTICAL TRADE BALANCES ACROSS GLOBAL REPORTING ECONOMIES

This analysis examines whether pharmaceutical export specialization corresponds to stronger external trade positions across internationally dispersed economies. United Nations Comtrade provides 239 complete annual observations across 16 economies during 2010 to 2025. Descriptive statistics, Pearson and Spearman correlations, economy mean centering, and a balanced sample comparison distinguish pooled relationships from sensitivity to coverage and persistent national differences. Biological products export share correlates positively with normalized pharmaceutical trade balance at 0.4790, whereas bulk and packaged medicaments share correlate negatively at −0.3419 and −0.2830. All directions persist across rank and balanced sample comparisons. After economy mean centering, the bulk relationship weakens to −0.1211, indicating substantial dependence on persistent national differences. Within fourteen fully observed economies, biological export share rises by 16.87 percentage points between the endpoints while average normalized trade balance changes little. These findings distinguish specialization within exports from performance relative to imports without establishing causal mechanisms. The contribution qualifies specialization-based interpretations of pharmaceutical competitiveness and supports monitoring export composition alongside import requirements before directing industrial resources.